Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MN › Shoreview › NPI 1427080415
Supplier

Fairview Pharmacy Services LLC

Fairview Pharmacy Services LLC was paid $4.13M by Medicaid between Jan 2018 and Dec 2024, across 25 billing codes. Its largest line is J2315, Injection, naltrexone, depot form, 1 mg — 24% of everything it billed.

33Billing provider infoFAIRVIEW PHARMACY SERVICES LLC
SHOREVIEW, MN 55126
33aNPI1427080415assigned 07/07/2006
28Total paid$4.13M
24GClaims78,588
24DCodes billed25
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Durable Medical Equipment & Medical Supplies providers in Minnesota

Rank by total paid#28 of 319
Median peer was paid$23K
This provider vs. median178×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official BADLANI, SAMEER controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20189,803$280K
201912,318$1.15M
202010,814$840K
20219,742$500K
202212,960$375K
202313,879$545K
2024incomplete9,072$443K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J2315 Injection, naltrexone, depot form, 1 mg 24% 868 764 $991K
A9276 Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply 22% 4,587 3,721 $929K
A4230 Infusion set for external insulin pump, non needle cannula type 12% 4,293 3,690 $507K
K0553 Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service 8.4% 8,058 6,656 $348K
A9277 Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system 8.0% 2,061 1,541 $329K
A4239 Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service 7.6% 6,451 6,113 $314K
A9274 External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories 4.9% 414 375 $204K
A4232 Syringe with needle for external insulin pump, sterile, 3 cc 2.5% 2,970 2,525 $105K
J7518 Mycophenolic acid, oral, 180 mg 2.3% 2,304 2,070 $95K
J7507 Tacrolimus, immediate release, oral, 1 mg 1.8% 9,056 6,408 $74K
A9278 Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system 1.4% 256 240 $57K
Q0511 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period <1% 11,601 10,491 $35K
13 more codes
Q0512 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period <1% 13,383 $31K
A4225 Supplies for external insulin infusion pump, syringe type cartridge, sterile, each <1% 1,432 $30K
J7517 Mycophenolate mofetil, oral, 250 mg <1% 5,984 $28K
A4224 Supplies for maintenance of insulin infusion catheter, per week <1% 209 $20K
J7515 Cyclosporine, oral, 25 mg <1% 619 $10K
K0554 Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system <1% 100 $10K
E2103 Non-adjunctive, non-implanted continuous glucose monitor or receiver <1% 163 $8K
J7639 Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 13 $7K
Q0513 Pharmacy dispensing fee for inhalation drug(s); per 30 days <1% 374 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 3,313 $229.88
A4253 Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips <1% 16 $89.88
Q0510 Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant <1% 33 $40.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 30 $34.29

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBADLANI, SAMEER (CHAIRMAN OF THE BOARD)
Same official

Other billing entities under BADLANI, SAMEER

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.